This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
stock-price-movement: Archive
Radcom (RDCM) Soars 5.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Radcom (RDCM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RDCMPositive Net Change NTCTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Energy Fuels (UUUU) Surges 9.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Energy Fuels (UUUU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
UUUUPositive Net Change CDENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ams-OSRAM AG Unsponsored ADR (AMSSY) Surges 11.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
ams-OSRAM AG Unsponsored ADR (AMSSY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
AMSSYNo Net Change SQNSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Confluent (CFLT): Can Its 7.6% Jump Turn into More Strength?
by Zacks Equity Research
Confluent (CFLT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CFLTPositive Net Change SEMRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
All You Need to Know About Mosaic (MOS) Rating Upgrade to Strong Buy
by Zacks Equity Research
Mosaic (MOS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
MOSNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Peraso (PRSO) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Peraso (PRSO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
PRSOPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Cushman & Wakefield (CWK) a New Strong Buy Stock
by Zacks Equity Research
Cushman & Wakefield (CWK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
CWKPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
TEMENOS GROUP (TMSNY) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
TEMENOS GROUP (TMSNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TMSNYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Steelcase (SCS) Rating Upgrade to Strong Buy
by Zacks Equity Research
Steelcase (SCS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
SCSNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Medical Properties (MPW) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Medical Properties (MPW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
MPWNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Labcorp (LH) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
LHPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Envela (ELA) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Envela (ELA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ELAPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Princeton Bancorp (BPRN) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Princeton Bancorp (BPRN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BPRNNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Cummins (CMI) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Cummins (CMI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CMINegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Solaris Energy Infrastructure, Inc. (SEI) Moves 9.4% Higher: Will This Strength Last?
by Zacks Equity Research
Solaris Energy Infrastructure, Inc. (SEI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SEINegative Net Change USACNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Voyager Therapeutics (VYGR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
VYGRNegative Net Change ALVONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength?
by Zacks Equity Research
Septerna, Inc. (SEPN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SEPNPositive Net Change GYRENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Bears are Losing Control Over Wex (WEX), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Wex (WEX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
WEXNegative Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
TopBuild (BLD) Moves 10.1% Higher: Will This Strength Last?
by Zacks Equity Research
TopBuild (BLD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BLDNegative Net Change HLMNNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Global Ship Lease (GSL) Loses 8.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Global Ship Lease (GSL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
GSLNegative Net Change
rsi stock-price-movement
Down 17.0% in 4 Weeks, Here's Why You Should You Buy the Dip in Jefferies (JEF)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Jefferies (JEF) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
JEFNegative Net Change
rsi stock-price-movement
Here's Why Rithm (RITM) is Poised for a Turnaround After Losing 12.4% in 4 Weeks
by Zacks Equity Research
Rithm (RITM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
RITMNegative Net Change
rsi stock-price-movement
Vir Biotechnology (VIR) Surges 6.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Vir Biotechnology (VIR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
VIRNegative Net Change TARSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Stoke Therapeutics (STOK) Surges 11.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Stoke Therapeutics (STOK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
STOKNegative Net Change JANXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Intellia Therapeutics (NTLA) Soars 19.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Intellia Therapeutics (NTLA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
NTLAPositive Net Change ACIUNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today